Experimental mouse model of NMOSD produced by facilitated brain delivery of NMO-IgG by microbubble-enhanced low-frequency ultrasound in experimental allergic encephalomyelitis mice
Experimental mouse model of NMOSD produced by facilitated brain delivery of NMO-IgG by microbubble-enhanced low-frequency ultrasound in experimental allergic encephalomyelitis mice
复制标题
通过微泡增强低频超声促进实验性过敏性脑脊髓炎小鼠脑部递送 NMO-IgG 产生 NMOSD 实验性小鼠模型
DOI:
10.1016/j.msard.2020.102473
复制
发表时间:
2020-11-01
影响因子:
4
通讯作者:
Guan, Yangtai
中科院分区:
文献类型:
--
作者:
Luo, Jiaying;Xie, Chong;Guan, Yangtai
Although optic neuritis and myelitis are the core clinical characteristics of neuromyelitis optica spectrum disorders (NMOSD), appropriate animal models of NMOSD with myelitis and optic neuritis are lacking. we developed a mouse model of NMOSD by intravenously injecting 100 mu g neuromyelitis optica immunoglobulin G antibody (NMO-IgG) and complement into experimental allergic encephalomyelitis (EAE) mice after reversible blood-brain barrier (BBB) opening by microbubble-enhanced low-frequency ultrasound (MELFUS). Animals were assessed by histopathology. We found noticeable inflammation and demyelination concomitant with the loss of aquaporin-4 (AQP4) and glial fibrillary acidic protein (GFAP) expression in the spinal cord, brain and optic nerve, as well as human IgG and C9neo deposition. Thus, with the help of MELFUS, we established an NMOSD mouse model with the core lesions of NMOSD by applying a considerably lower dose of human NMOIgG, which may help identify the pathogenesis and facilitate the development of other neuroimmune disease models in the future.